Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer; Chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02066675
What this trial is testing

Trabectedin First Line Therapy In Unfit Sarcoma Study

Who this might be right for
Metastatic and Locally Advanced Soft Tissue Tumor Patients Unfit to ReceiveStandard Chemotherapy
Italian Sarcoma Group 24
Testing effectiveness (Phase 2)UnknownNCT05134519
What this trial is testing

RC48 for Neoadjuvant Chemotherapy of HER2 Positive Breast Cancer

Who this might be right for
Breast CancerHER2-positive Breast Cancer
Xijing Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00988936
What this trial is testing

Efficacy Study of [F-18]RGD-K5 Positron Emission Tomography (PET) as a Tool to Monitor Response to an Anti-angiogenic Drug

Who this might be right for
Metastatic Breast CancerMetastatic Colon/Rectum CancerNon-squamous Non-small Cell Lung Cancer
Siemens Molecular Imaging 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT05715931
What this trial is testing

Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma

Who this might be right for
Adenocarcinoma of the StomachAdenocarcinoma of Esophagogastric JunctionHER2-positive Gastric Cancer
Yu jiren 30
Testing effectiveness (Phase 2)Ended earlyNCT01523639
What this trial is testing

A Randomized, Placebo-controlled, Double-blind Phase II Study Evaluating if Glucophage Can Avoid Liver Injury Due to Chemotherapy Associated Steatosis

Who this might be right for
Colorectal CancerSteatohepatitis
Austrian Breast & Colorectal Cancer Study Group 8
Not applicableActive Not RecruitingNCT03255577
What this trial is testing

Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy For Locally Advanced Breast Cancer

Who this might be right for
Breast CancerLocally Advanced Breast Cancer
Memorial Sloan Kettering Cancer Center 162
Testing effectiveness (Phase 2)Study completedNCT01553019
What this trial is testing

Postoperative Proton Radiotherapy With Chemo for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University of Florida 2
Testing effectiveness (Phase 2)Ended earlyNCT03237611
What this trial is testing

Low Dose Aprepitant for Patients Receiving Carboplatin

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
Albert Einstein College of Medicine 15
Not applicableLooking for participantsNCT05690802
What this trial is testing

The Safety and Effectiveness of Palonosetron Hydrochloride Capsule Was Used to CINV

Who this might be right for
Nausea and Vomiting
Xijing Hospital 1,060
Not applicableLooking for participantsNCT06386302
What this trial is testing

Chidamide, Venetoclax, and Azacitidine for Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
AMLAcute Myeloid Leukemia
Institute of Hematology & Blood Diseases Hospital, China 184
Large-scale testing (Phase 3)Ended earlyNCT00082095
What this trial is testing

To Compare Treatment With Doxorubicin or Capecitabine for Metastatic Breast Cancer in Women 60 Years and Older

Who this might be right for
Metastatic Breast Cancer
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 62
Testing effectiveness (Phase 2)Study completedNCT00003957
What this trial is testing

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Fox Chase Cancer Center 3
Large-scale testing (Phase 3)Study completedNCT01631357
What this trial is testing

Study of Chemotherapy Combination With Autologous Cytokine-Induced Killer Cell Immunotherapy to Treat Lung Cancer

Who this might be right for
Non-small Cell Lung CancerSquamous Cell Carcinoma
Tianjin Medical University Cancer Institute and Hospital 96
Early research (Phase 1)WithdrawnNCT04762901
What this trial is testing

LCI-BRE-MTN-NIR-001:Ph I Study of Niraparib in Combo With Standard Chemo in Metastatic Trip Neg Breast Cancer

Who this might be right for
Breast Cancer
Wake Forest University Health Sciences
Testing effectiveness (Phase 2)Looking for participantsNCT07537400
What this trial is testing

Patients Between the Ages of 12 Months to 21 Years With Newly-Diagnosed High-Risk Neuroblastoma Will Receive Children's Oncology Group (COG) Type Recommended Therapy With the Addition of Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) to Induction Cycles 1-5

Who this might be right for
High-Risk Neuroblastoma
Shaare Zedek Medical Center 10
Not applicableStudy completedNCT01563211
What this trial is testing

Predictive Model of Therapy Outcomes in Breast Cancer Patients

Who this might be right for
Toxicity From Medication (Endocrine Treatment and Chemotherapy) Given for Breast Cancer Treatment.
Imperial College London 70
Large-scale testing (Phase 3)Study completedNCT00002539
What this trial is testing

Combination Chemotherapy and Surgery With or Without G-CSF in Treating Patients With Osteosarcoma

Who this might be right for
Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC 214
Large-scale testing (Phase 3)Study completedNCT03856411
What this trial is testing

Evaluate the Efficacy and Safety of Toripalimab or Placebo Combined With Chemotherapy in Treatment-naive Advanced NSCLC

Who this might be right for
Treatment-naive Advanced Non-small Cell Lung Cancer
Shanghai Junshi Bioscience Co., Ltd. 465
Large-scale testing (Phase 3)Looking for participantsNCT06754644
What this trial is testing

Evaluate Efficacy, and Safety of QL2107 Plus Chemo and Compare With Keytruda in Participants With IV nqNSCLC

Who this might be right for
NSCLC
Qilu Pharmaceutical Co., Ltd. 808
Not applicableWithdrawnNCT00430313
What this trial is testing

Effects of Acupoint Electro-stimulation on Preventing Nausea and Vomiting Induced by Cisplatin or Oxaliplatin

Who this might be right for
Liver CancerLiver Metastasis
M.D. Anderson Cancer Center
Next Page